Cytovance recently appeared on the Outsourced Pharma Large Molecule Capacity Update to share how our available capacity, US-based manufacturing, and high scale-up success rate are helping industry customers meet product milestones in 2024 and beyond.

View the video below to hear from Axel Schleyer, CCO, and Brent Van Rite, Sr. Director of Manufacturing, about our 20+ years of experience and current microbial and mammalian capabilities.